Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindi Masson

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Current Opinion in HIV and AIDS|December 3, 2015
Genital inflammation, immune activation and risk of sexual HIV acquisitionJo-Ann S Passmore, Heather B Jaspan, Lindi Masson
Frontiers in Public Health|March 20, 2023
Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape TownElise Smith, Lindi Masson, Jo-Ann S Passmore, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 26, 2023
Advances in mass spectrometry technologies to characterize cervicovaginal microbiome functions that impact spontaneous preterm birthLindi Masson, Jenna Wilson, Aleya Sarah Amir Hamzah, et al.
Sexually Transmitted Diseases|October 1, 2021
Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact AnalysisAngela Kairu, Lindi Masson, Jo-Ann S Passmore, et al.
Retrovirology|July 4, 2020
HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responsesEvelyn Ngwa Lumngwena, Simon Metenou, Lindi Masson, et al.
Clinical Obstetrics and Gynecology|July 29, 2021
Recent Advances and New Challenges in Cisgender Women's Gynecologic and Obstetric Health in the Context of HIVJennifer Deese, Renee Heffron, Heather Jaspan, et al.
The Lancet. HIV|April 2, 2026
The vaginal microbiome and HIV acquisition riskLindi Masson, Nina Radzey, Andrea G Abrahams, et al.
Scientific Reports|February 18, 2026
The cost-effectiveness of male-partner treatment to prevent recurrence of bacterial vaginosisYing Zhang, Catriona S Bradshaw, Lindi Masson, et al.
Current Opinion in Infectious Diseases|February 8, 2023
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settingsFezile Khumalo, Jo-Ann S Passmore, Monalisa Manhanzva, et al.
Frontiers in Reproductive Health|October 28, 2022
The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium <i>in vitro</i>David Tyssen, Anna C Hearps, Kalyani Guntur, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Opinion in HIV and AIDS|December 3, 2015
Genital inflammation, immune activation and risk of sexual HIV acquisitionJo-Ann S Passmore, Heather B Jaspan, Lindi Masson
Frontiers in Public Health|March 20, 2023
Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape TownElise Smith, Lindi Masson, Jo-Ann S Passmore, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 26, 2023
Advances in mass spectrometry technologies to characterize cervicovaginal microbiome functions that impact spontaneous preterm birthLindi Masson, Jenna Wilson, Aleya Sarah Amir Hamzah, et al.
Sexually Transmitted Diseases|October 1, 2021
Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact AnalysisAngela Kairu, Lindi Masson, Jo-Ann S Passmore, et al.
Retrovirology|July 4, 2020
HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responsesEvelyn Ngwa Lumngwena, Simon Metenou, Lindi Masson, et al.
Clinical Obstetrics and Gynecology|July 29, 2021
Recent Advances and New Challenges in Cisgender Women's Gynecologic and Obstetric Health in the Context of HIVJennifer Deese, Renee Heffron, Heather Jaspan, et al.
The Lancet. HIV|April 2, 2026
The vaginal microbiome and HIV acquisition riskLindi Masson, Nina Radzey, Andrea G Abrahams, et al.
Scientific Reports|February 18, 2026
The cost-effectiveness of male-partner treatment to prevent recurrence of bacterial vaginosisYing Zhang, Catriona S Bradshaw, Lindi Masson, et al.
Current Opinion in Infectious Diseases|February 8, 2023
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settingsFezile Khumalo, Jo-Ann S Passmore, Monalisa Manhanzva, et al.
Frontiers in Reproductive Health|October 28, 2022
The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium <i>in vitro</i>David Tyssen, Anna C Hearps, Kalyani Guntur, et al.
Pageof 6